Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: A prospective phase III randomized study of the southwest oncology group
Paul A. Bunn, John Crowley, Karen Kelly, Mark B. Hazuka, Kristie Beasley, Christine Upchurch, Robert Livingston
Dive into the research topics of 'Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: A prospective phase III randomized study of the southwest oncology group'. Together they form a unique fingerprint.